| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 17th March 2020 | John W. Higuchi | 220,000 | Open or private purchase | $0.32 | $69,542.00 |
| 31st December 2019 | Mahesh V. Patel | 40,000 | Open or private purchase | $0.38 | $15,340.00 |
| 10th December 2019 | Mahesh V. Patel | 25,000 | Open or private purchase | $0.40 | $9,975.00 |
| 4th December 2019 | Mahesh V. Patel | 145,000 | Exercise of derivative | $0.00 | |
| 4th December 2019 | Morgan R Brown | 17,250 | Open or private sale | $0.41 | $7,075.95 |
| 4th December 2019 | Mahesh V. Patel | 43,500 | Open or private sale | $0.41 | $17,835.00 |
| 4th December 2019 | Morgan R Brown | 57,500 | Exercise of derivative | $0.00 | |
| 26th November 2019 | Mahesh V. Patel | 1,100 | Open or private purchase | $0.43 | $469.70 |
| 26th November 2019 | Mahesh V. Patel | 21,928 | Open or private purchase | $0.43 | $9,385.18 |
| 26th November 2019 | Mahesh V. Patel | 1,272 | Open or private purchase | $0.43 | $542.51 |
Lipocine
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Lipocine, Inc. focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.
Ticker: LPCN
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 1535955
Employees: 12
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Tesla sues to block Trump tariffs on trade with China
23rd September 2020
Japanese fashionista aiming to put Filipino kids on runway to success
22nd September 2020
BlackRock, JPMorgan climate votes at odds as new rules loom
22nd September 2020